tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
Holding ASRT?
Track your performance easily

Assertio Therapeutics (ASRT) Income Statement

1,075 Followers

Assertio Therapeutics Income Statement

Last quarter (Q3 2024), Assertio Therapeutics's total revenue was $29.20M, a decrease of -18.03% from the same quarter last year. In Q3, Assertio Therapeutics's net income was $-2.92M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 125.76M$ 152.07M$ 156.23M$ 111.01M$ 106.28M$ 229.50M
Cost of Revenue
$ 37.34M$ 27.02M$ 18.75M$ 15.83M$ 19.87M$ 9.51M
Gross Profit
$ 88.43M$ 125.05M$ 137.49M$ 95.18M$ 86.40M$ 220.00M
Operating Expense
$ 104.90M$ 109.01M$ 79.39M$ 80.75M$ 133.32M$ 220.75M
Operating Income
$ -43.33M$ -243.54M$ 39.41M$ 9.42M$ -82.16M$ -747.00K
Net Non Operating Interest Income Expense
$ -11.22M$ -13.30M$ -7.96M$ -10.22M$ -15.93M$ -58.39M
Other Income Expense
$ 11.83M$ -256.80M$ -18.96M$ 3.67M$ -52.57M$ -163.35M
Pretax Income
$ -42.69M$ -254.05M$ 31.17M$ -553.00K$ -45.51M$ -222.48M
Tax Provision
$ 25.80M$ 77.89M$ -78.46M$ 728.00K$ -17.37M$ -5.28M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -68.49M$ -331.94M$ 109.63M$ -1.28M$ -28.14M$ -217.20M
Basic EPS
$ -1.45$ -4.67$ 2.33$ -0.03$ -1.08$ -12.28
Diluted EPS
$ -1.43$ -4.67$ 2.03$ -0.03$ -1.08$ -12.28
Basic Average Shares
$ 380.84M$ 71.03M$ 47.00M$ 43.17M$ 26.21M$ 17.68M
Diluted Average Shares
$ 366.83M$ 71.03M$ 54.67M$ 43.17M$ 26.21M$ 17.68M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
-----$ 1.88
Rent Expense Supplemental
------
Total Expenses
$ 142.24M$ 136.03M$ 98.14M$ 96.59M$ 153.19M$ 230.25M
Net Income From Continuing And Discontinued Operation
$ -68.49M$ -331.94M$ 109.63M$ -1.28M$ -28.14M$ -217.20M
Normalized Income
$ -9.02M$ 58.87M---$ -53.88M
Interest Expense
-----$ 34.63M
EBIT
$ -39.76M$ -251.13M$ 38.89M$ 9.65M$ -29.59M$ -187.86M
EBITDA
$ -15.41M$ -222.90M$ 72.29M$ 38.73M$ -3.16M$ -84.91M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis